Mizuho Securities Downgrades Allergen (AGN) to Neutral Following AbbVie Acquisition
Tweet Send to a Friend
Mizuho Securities analyst Irina Koffler downgraded Allergen (NYSE: AGN) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


